Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Diabetic Retinopathy | 4 | 2017 | 347 | 1.87 | Why? |
| Neovascularization, Pathologic | 3 | 2017 | 305 | 1.14 | Why? |
| Genes, p53 | 1 | 2018 | 20 | 0.77 | Why? |
| Curcuma | 1 | 2019 | 65 | 0.77 | Why? |
| Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 35 | 0.76 | Why? |
| Microbiological Techniques | 1 | 2021 | 232 | 0.75 | Why? |
| Terminalia | 1 | 2016 | 8 | 0.68 | Why? |
| Retinal Neovascularization | 1 | 2017 | 29 | 0.68 | Why? |
| Plant Extracts | 2 | 2019 | 1514 | 0.63 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2018 | 310 | 0.62 | Why? |
| Diabetic Nephropathies | 1 | 2019 | 315 | 0.57 | Why? |
| Oxidative Stress | 4 | 2019 | 2050 | 0.54 | Why? |
| Fatty Acids, Omega-3 | 1 | 2017 | 306 | 0.52 | Why? |
| Fibrinolysis | 1 | 2017 | 521 | 0.46 | Why? |
| Hyperglycemia | 3 | 2019 | 1363 | 0.46 | Why? |
| Angiotensin II | 1 | 2017 | 601 | 0.43 | Why? |
| Whole Genome Sequencing | 1 | 2021 | 3239 | 0.41 | Why? |
| Phytotherapy | 1 | 2016 | 743 | 0.39 | Why? |
| MicroRNAs | 1 | 2021 | 1787 | 0.35 | Why? |
| Diabetes Mellitus | 2 | 2021 | 8207 | 0.33 | Why? |
| Drug Discovery | 1 | 2021 | 3092 | 0.32 | Why? |
| Computational Biology | 1 | 2021 | 4514 | 0.30 | Why? |
| Renin-Angiotensin System | 2 | 2020 | 3661 | 0.29 | Why? |
| Diabetes Complications | 1 | 2016 | 2358 | 0.27 | Why? |
| Blood Coagulation | 1 | 2017 | 2768 | 0.26 | Why? |
| Hypoglycemic Agents | 1 | 2016 | 2165 | 0.26 | Why? |
| Antineoplastic Agents | 2 | 2020 | 3550 | 0.26 | Why? |
| Asthma | 1 | 2020 | 4383 | 0.23 | Why? |
| Drugs, Chinese Herbal | 1 | 2017 | 2760 | 0.22 | Why? |
| Chlorophyta | 1 | 2020 | 36 | 0.22 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2017 | 3892 | 0.21 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.19 | Why? |
| alpha-Linolenic Acid | 1 | 2017 | 7 | 0.18 | Why? |
| Antioxidants | 2 | 2019 | 1593 | 0.17 | Why? |
| Angiogenesis Inducing Agents | 1 | 2016 | 11 | 0.17 | Why? |
| Antithrombin III | 1 | 2017 | 67 | 0.17 | Why? |
| Pharmacovigilance | 1 | 2021 | 501 | 0.16 | Why? |
| Eicosapentaenoic Acid | 1 | 2017 | 106 | 0.16 | Why? |
| Plasminogen Activator Inhibitor 1 | 1 | 2017 | 162 | 0.16 | Why? |
| Animals | 8 | 2021 | 78931 | 0.15 | Why? |
| Docosahexaenoic Acids | 1 | 2017 | 145 | 0.15 | Why? |
| Microglia | 1 | 2019 | 357 | 0.15 | Why? |
| Central Nervous System | 1 | 2020 | 701 | 0.14 | Why? |
| Genome-Wide Association Study | 1 | 2021 | 1648 | 0.13 | Why? |
| Curcumin | 1 | 2019 | 396 | 0.13 | Why? |
| Drug Industry | 1 | 2021 | 689 | 0.13 | Why? |
| Angiogenesis Inhibitors | 1 | 2017 | 395 | 0.12 | Why? |
| Retina | 1 | 2017 | 424 | 0.12 | Why? |
| Lipid Metabolism | 1 | 2016 | 572 | 0.12 | Why? |
| Alzheimer Disease | 1 | 2022 | 1020 | 0.11 | Why? |
| Fibrinogen | 1 | 2017 | 1048 | 0.11 | Why? |
| von Willebrand Factor | 1 | 2017 | 668 | 0.11 | Why? |
| Neoplasms | 2 | 2020 | 17251 | 0.11 | Why? |
| Geriatrics | 1 | 2020 | 947 | 0.10 | Why? |
| Lipids | 1 | 2016 | 1079 | 0.10 | Why? |
| Parkinson Disease | 1 | 2022 | 1414 | 0.10 | Why? |
| Immunoglobulins, Intravenous | 1 | 2020 | 2705 | 0.09 | Why? |
| Humans | 20 | 2022 | 930598 | 0.09 | Why? |
| Anticoagulants | 2 | 2020 | 9563 | 0.08 | Why? |
| Inflammation Mediators | 1 | 2019 | 2654 | 0.08 | Why? |
| Immunotherapy | 1 | 2020 | 2421 | 0.08 | Why? |
| Genetic Variation | 1 | 2021 | 3919 | 0.08 | Why? |
| Inflammation | 3 | 2020 | 13255 | 0.08 | Why? |
| Communicable Diseases | 1 | 2021 | 2148 | 0.08 | Why? |
| Biological Products | 1 | 2020 | 2331 | 0.07 | Why? |
| Pharmaceutical Preparations | 1 | 2020 | 1897 | 0.07 | Why? |
| Pediatrics | 1 | 2020 | 2969 | 0.07 | Why? |
| Disease Management | 1 | 2022 | 6841 | 0.06 | Why? |
| Protein Binding | 1 | 2020 | 11430 | 0.06 | Why? |
| India | 1 | 2021 | 11875 | 0.06 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.06 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.06 | Why? |
| Blood Glucose | 1 | 2017 | 3642 | 0.06 | Why? |
| Nervous System Diseases | 1 | 2021 | 4092 | 0.06 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.06 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.05 | Why? |
| Dipeptides | 1 | 2021 | 106 | 0.05 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.05 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.05 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.05 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.05 | Why? |
| Infant | 1 | 2020 | 30274 | 0.04 | Why? |
| Stroke | 1 | 2020 | 8839 | 0.04 | Why? |
| Hyperbaric Oxygenation | 1 | 2020 | 268 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.04 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.04 | Why? |
| Child | 2 | 2021 | 70012 | 0.03 | Why? |
| Immunization, Passive | 2 | 2020 | 10067 | 0.03 | Why? |
| Peptide Hydrolases | 1 | 2021 | 1269 | 0.03 | Why? |
| Dogs | 1 | 2021 | 2529 | 0.03 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.03 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.03 | Why? |
| Seizures | 1 | 2020 | 1163 | 0.03 | Why? |
| Swine | 1 | 2021 | 3352 | 0.03 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.02 | Why? |
| Molecular Dynamics Simulation | 1 | 2021 | 4155 | 0.02 | Why? |
| Aged | 2 | 2021 | 215776 | 0.02 | Why? |
| Artificial Intelligence | 1 | 2021 | 3543 | 0.02 | Why? |
| Molecular Docking Simulation | 1 | 2021 | 6902 | 0.02 | Why? |
| Protease Inhibitors | 1 | 2021 | 3630 | 0.02 | Why? |
| Female | 2 | 2021 | 380317 | 0.01 | Why? |
| Male | 1 | 2020 | 367725 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.01 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
Behl's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(116)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(111)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_